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Background: Overweight and obesity in adulthood are linked to
an increased risk for death and disease. Their potential effect on
life expectancy and premature death has not yet been described.
Objective: To analyze reductions in life expectancy and in-
creases in premature death associated with overweight and obe-
sity at 40 years of age.
Design: Prospective cohort study.
Setting: The Framingham Heart Study with follow-up from 1948
to 1990.
Participants: 3457 Framingham Heart Study participants who
were 30 to 49 years of age at baseline.
Measurements: Mortality rates specific for age and body mass
index group (normal weight, overweight, or obese at baseline)
were derived within sex and smoking status strata. Life expect-
ancy and the probability of death before 70 years of age were
analyzed by using life tables.
Results: Large decreases in life expectancy were associated with
overweight and obesity. Forty-year-old female nonsmokers lost
3.3 years and 40-year-old male nonsmokers lost 3.1 years of life
expectancy because of overweight. Forty-year-old female non-
smokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8
years because of obesity. Obese female smokers lost 7.2 years
and obese male smokers lost 6.7 years of life expectancy com-
pared with normal-weight smokers. Obese female smokers lost
13.3 years and obese male smokers lost 13.7 years compared with
normal-weight nonsmokers. Body mass index at ages 30 to 49
years predicted mortality after ages 50 to 69 years, even after
adjustment for body mass index at age 50 to 69 years.
Conclusions: Obesity and overweight in adulthood are associ-
ated with large decreases in life expectancy and increases in early
mortality. These decreases are similar to those seen with smoking.
Obesity in adulthood is a powerful predictor of death at older
ages. Because of the increasing prevalence of obesity, more effi-
cient prevention and treatment should become high priorities in
public health.
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The increasing prevalence of overweight and obesity,coupled with their associations with death, disability,
and disease, has led to their identification as a major, po-
tentially preventable cause of premature morbidity and
death (1–9). However, it is difficult to estimate the public
health impact of overweight and obesity because of com-
plex interactions with age; smoking; and obesity-related
risk factors, such as diabetes, hypertension, and lipid dis-
orders (8, 10–12). The observed relationship between
body mass index (BMI) and mortality has been described
as J-shaped; mortality increases as a result of underweight,
overweight, and obesity. However, preexisting illness and
inadequate control of smoking may cause at least part of
the increased mortality at very low weight (8).
Consequently, there have been no robust estimates of
life expectancy lost as a result of obesity. A primary reason
is the lack of understanding of probable, healthy, or un-
healthy weight trajectories over the life course. Conclusions
regarding appropriate weight trajectories between adult-
hood and older age are complicated by uncertainties about
age-appropriate measurements of obesity and the effects of
smoking, obesity-associated risk factors for cardiovascular
disease, and unintended weight loss (13, 14).
We provide an estimate of the effect of obesity and
overweight in adulthood on life expectancy, implicitly tak-
ing into account the various possible weight trajectories
throughout the life course. We take advantage of the co-
hort follow-up made available by the Framingham Heart
Study to analyze the differences in life course for various
BMI groups. We make no assumptions about the relation-
ship between BMI and mortality at older ages. Our pri-
mary objective was to analyze the reductions in life expect-
ancy associated with overweight and obesity at 40 years
of age.
METHODS
Data Source
The Framingham Heart Study is a longitudinal study
with excellent follow-up on mortality. The original study
cohort involved 5209 adults, age 28 through 62 years, re-
siding in Framingham, Massachusetts, between 1948 and
1951 (15). To examine the effect of overweight and obesity
in adulthood, we used the data from more than 40 years of
follow-up (examinations 1 through 21) on age at death for
persons 30 through 49 years of age at baseline (n  3607).
Height and weight were measured at baseline (7, 15).
Smoking status at baseline was defined categorically as self-
reported current smoker or nonsmoker. No information
was available on smoking status before study entry. Infor-
mation on all three variables was available for 3582 partic-
ipants (99%). Because the relationship between weight and
mortality is affected by underlying disease (8, 14, 16), we
excluded participants who had cardiovascular disease (17)
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at baseline or died within 4 years of follow-up (63 partic-
ipants, including 50 deaths). Because our analysis focused
on the risk for death associated with overweight and obe-
sity, we also excluded 62 underweight persons (BMI
18.5 kg/m2). The final analyses involved 3457 participants
(1550 men and 1907 women).
We analyzed the effect of potential confounders on the
relationship between obesity and mortality (6, 8, 18). Of
the 3457 participants examined, hypertension and diabetes
status was available for all participants, and physical activ-
ity level was available for 2893 (84%) participants. Total
serum cholesterol level was available for 2127 (62%) par-
ticipants and was therefore not taken into account. We
defined hypertension at baseline as either systolic blood
pressure of 160 mm Hg or greater or diastolic blood pres-
sure of 95 mm Hg or greater in two repeated measure-
ments. Physical activity (a continuous index derived from
hours of activity and rest) was not available until examina-
tion 4 (approximately 8 years after baseline). Level of edu-
cation at baseline was available for 3350 (97%) partici-
pants. Potential confounders were analyzed by using only
complete cases.
BMI Group Classification
Body mass index at baseline was calculated as weight
in kg/height in m2. We defined three BMI categories based
on World Health Organization guidelines (2): group I
(normal weight), BMI of 18.5 to 24.9 kg/m2; group II
(overweight), BMI of 25 to 29.9 kg/m2; and group III
(obese), BMI greater than or equal to 30 kg/m2 (including
19 people with BMI 40 kg/m2).
Survival Analysis
We used S-Plus 2000 (MathSoft, Inc., Seattle, Wash-
ington) for all statistical analyses. Survival curves for each
BMI group were compared by using Kaplan–Meier plots.
We assessed the association between BMI group at baseline
and mortality over the 40 years of follow-up by using Cox
proportional hazards analysis, with age as the time scale.
The effect of BMI was analyzed separately within strata
defined by sex and smoking status at baseline. We tested
the proportionality of hazards assumption by analysis of
the Schoenfeld residuals (19, 20). Statistical significance
was set at the 5% level.
Life Course Analysis
Within each stratum, we estimated age-specific mor-
tality rates for each BMI group by using Poisson regression
analysis; age at follow-up and BMI group at baseline were
categorical variables. Although the hazard ratios estimated
for BMI group from this analysis are equivalent to those
estimated from the Cox analyses, Poisson regression also
optimizes the hazard associated with each age at follow-up.
Life tables were derived for each BMI group, representing
populations that were 40 years of age and free of cardio-
vascular disease at study entry. Conversions between mor-
tality rates and probabilities assumed that within each sin-
gle age interval, the hazard is constant. The life expectancy
at 90 years of age was assumed to be a constant 4.53 for
men and 5.05 for women for each BMI group (based on
life expectancies of the total Framingham Study sample
[21]). The main outcome measure, life expectancy at 40
years of age, was calculated as the mean age at death within
a life-table population. Confidence intervals for the life
table measures were calculated by using a bootstrap proce-
dure, based on 10 000 replicates. We report the bootstrap
bias–correct, adjusted 95% CIs (using the bias-corrected
accelerated percentile interval algorithm) (22). Although
computationally demanding, the bootstrap procedure is
easier than an analytical alternative that includes both the
variance of the Poisson model and the variance of the life
table.
Role of the Funding Source
The Framingham Heart Study was conducted and
supported by the National Heart, Lung, and Blood Insti-
tute (NHLBI) in collaboration with the Framingham
Heart Study Investigators. The NHLBI reviewed this arti-
cle for scientific content and consistency of data interpre-
tation with previous Framingham Heart Study publica-
Table 1. Characteristics of Original Framingham Heart Study
Participants, Age 30 to 49 Years at Baseline (1948–1951)
BMI Group* Female
Nonsmoker
Female
Smoker
Male
Nonsmoker
Male
Smoker
4OOOOOOOOOOOn (%)OOOOOOOOOOO3
Group I 522 (52) 624 (70) 115 (38) 577 (46)
Group II 353 (35) 206 (23) 143 (47) 533 (43)
Group III 136 (13) 66 (7) 44 (15) 138 (11)
* Group I is normal weight, group II is overweight, and group III is obese.
BMI  body mass index.
Context
Middle-aged adults who are overweight or obese may
have shorter life expectancies than normal-weight adults,
but how much shorter?
Contribution
This analysis of data from the Framingham Heart Study
from 1948 to 1990 showed that, on average, adults who
were obese (body mass index [BMI]  30 kg/m2) at age
40 years lived 6 to 7 years less than their normal-weight
counterparts. Adults who were overweight (BMI, 25 to
29.9 kg/m2) and did not smoke lived about 3 years less
than normal-weight nonsmokers. Adults who were obese
and smoked lived 13 to 14 years less than normal-weight
nonsmokers.
Cautions
Descriptions of lost life expectancy do not necessarily pre-
dict length of life that could be gained from obesity pre-
vention or treatment programs.
–The Editors
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tions; significant comments were incorporated into the text
before submission for publication. The NHLBI had no
role in the design, conduct, analyses, and reporting of the
study or in the decision to submit the manuscript for pub-
lication. The Netherlands Heart Foundation and the
Netherlands Organization for Scientific Research funded
our study. Neither had any role in the design, conduct,
analyses and reporting of the study or in the decision to
submit the manuscript for publication.
RESULTS
The characteristics at baseline within the Framingham
Study cohort were generally as expected: The probability of
death increased with each higher category of BMI group,
the relationship between the prevalence of smoking and
BMI group was inverse (Table 1), and age generally in-
creased with each higher category of BMI group (7, 8, 23).
Although male nonsmokers were a small group and may
represent an unusual cohort for that time, they were ana-
lyzed in the same way as the other groups. We did this
because male nonsmokers had BMI-related risks similar to
those of female nonsmokers and to findings in previous
studies examining the relationship between BMI and mor-
tality.
BMI and Survival
With participants categorized by BMI at baseline, we
used Cox proportional hazards analysis to determine the
relative rate of death over the 40 years of follow-up. We
found that sex did not significantly modify the effect of
BMI but that smoking status at baseline did, as has been
previously described (10, 12, 24, 25). Additional analyses
were performed separately for strata defined by sex and
smoking status at baseline. The Figure illustrates the em-
pirical survival curves for each BMI group within each of
the four strata: female nonsmokers, female smokers, male
nonsmokers, and male smokers. The survival disadvantage
Figure. Kaplan–Meier survival estimates for body mass index (BMI) groups I, II, and III within sex and smoking strata.
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associated with BMI group II compared with BMI group I
is apparently smaller in smokers than in nonsmokers. The
hazard ratios for mortality associated with BMI group were
generally consistent between strata, although neither male
nor female smokers in BMI group II showed an increased
mortality risk (Table 2). The proportional hazards assump-
tion seemed appropriate for BMI, both by analysis of the
Schoenfeld residuals and by comparison of the Cox-
derived hazard ratios for two distinct follow-up periods
with approximately equal numbers of events (follow-up
years 4 to 28 [725 deaths]; and follow-up years 29 to 40
[919 deaths]). For all nonsmokers, sex-adjusted hazard ra-
tios for BMI group II were 1.47 in period 1 (95% CI, 1.06
to 2.04) versus 1.53 in period 2 (CI, 1.19 to 1.97), and
sex-adjusted hazard ratios for BMI group III were 2.05
(CI, 1.38 to 3.05) versus 2.27 (CI, 1.67 to 3.1). Hazard
ratios in the two periods were similar for each stratum.
Although earlier studies report a lack of risk associated
with overweight in smokers (8, 12, 23), this relationship is
complicated by the fact that lower weight may reflect
longer duration or stronger intensity of smoking (8), which
are themselves risk factors for death. We analyzed the effect
of various measures of smoking intensity (including future
smoking habits and number of cigarettes smoked per day)
and of excluding deaths within the first 20 years of
follow-up to account for smokers who have lower weight
because of underlying disease. In all analyses, the hazard
ratios for BMI group II remained 1. Therefore, why over-
weight confers an excess risk among nonsmokers but not
smokers remains unexplained.
Adjustment for physical activity and education had no
effect on the risks associated with BMI in any of the four
strata (Table 2) (6, 8). As expected (6, 8), adjustment for
hypertension and diabetes led to reductions in the mortal-
ity hazard ratios for obesity (Table 2). In participants with-
out diagnosed hypertension or diabetes at baseline, the
mortality hazard ratios for body weight were similar to
those of the total study sample (Table 2). We performed
our primary analyses on the total sample (n  3457) with-
out further adjustment. Secondary analyses were performed
on the 3025 participants without hypertension or diabetes
at baseline.
Table 2. Mortality Hazard Ratios for Body Mass Index Groups II and III Relative to Body Mass Index Group I, Derived from 40 Years
of Follow-up and Adjusted for Age*
BMI Group† Mortality Hazard Ratio (95% CI)
Female Nonsmoker Female Smoker Male Nonsmoker Male Smoker
Primary analysis with all participants (n  3457)
Group I‡ 1.00 1.00 1.00 1.00
Group II 1.51 (1.20–1.91) 1.01 (0.80–1.28) 1.42 (0.96–2.09) 1.14 (0.98–1.33)
Group III 2.27 (1.72–2.99) 2.01 (1.45–2.78) 1.92 (1.16–3.19) 1.92 (1.55–2.39)
Participants without hypertension or diabetes at
baseline (n  3025)
Group I‡ 1.00 1.00 1.00 1.00
Group II 1.38 (0.88–2.14) 1.06 (0.89–1.25) 1.51 (1.17–1.96) 1.02 (0.78–1.32)
Group III 2.20 (1.17–4.14) 1.95 (1.50–2.55) 2.35 (1.69–3.27) 1.84 (1.25–2.69)
All participants after adjustment for
hypertension and diabetes at baseline
(n  3457)
Group I‡ 1.00 1.00 1.00 1.00
Group II 1.41 (0.94–2.10) 1.09 (0.93–1.27) 1.48 (1.17–1.86) 0.89 (0.69–1.13)
Group III 1.58 (0.91–2.75) 1.62 (1.28–2.03) 1.95 (1.46–2.61) 1.75 (1.25–2.45)
Participants with physical activity information
from examination 4 and education
information from baseline examination
(n  2819)
Group I‡ 1.00 1.00 1.00 1.00
Group II 1.56 (1.02–2.39) 1.16 (0.98–1.38) 1.57 (1.21–2.04) 0.99 (0.76–1.31)
Group III 1.86 (1.06–3.29) 1.82 (1.41–2.33) 2.19 (1.60–3.00) 1.83 (1.24–2.71)
Participants with physical activity information
from examination 4 and education
information from baseline examination
after adjustment for physical activity and
education (n  2819)
Group I‡ 1.00 1.00 1.00 1.00
Group II 1.56 (1.02–2.39) 1.15 (0.97–1.37) 1.50 (1.15–1.95) 0.99 (0.76–1.30)
Group III 1.86 (1.06–3.29) 1.79 (1.39–2.30) 2.03 (1.47–2.79) 1.83 (1.23–2.72)
* BMI  body mass index.
† Group I is normal weight, group II is overweight, and group III is obese.
‡ Group I is the reference group.
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BMI, Life Expectancy, and Premature Mortality
We calculated the implications of the increases in risk
for death on the life course of 40-year-old participants,
classified as normal weight, overweight, or obese, and de-
termined their differences in life expectancy and premature
mortality. We focus on nonsmokers first. Forty-year-old
women and men in BMI group III lost 7.1 and 5.8 years of
life, respectively, compared with 40-year-old nonsmoking
women and men in BMI group I (Table 3). In addition,
40-year-old nonsmoking women and men in BMI group II
lost 3.3 and 3.1 years of life, respectively, compared with
nonsmoking women and men in BMI group I, although
the latter result was not statistically significant (Table 3).
We observed similar differences in life expectancy in the
participants who did not have hypertension or diabetes at
baseline (Table 3).
The decreases in life expectancy were reflected in
increased probabilities of premature death (defined as
death before the age of 70 years) (Table 4). Compared
with BMI group I, BMI group II had 4 to 5 more deaths/
100 persons and BMI group III had 10 to 11 more deaths/
100 persons between 40 and 70 years of age. This repre-
sents a 115% (women) and 81% (men) increased risk for
premature death in BMI group III (Table 4). We observed
increases of a similar magnitude in the participants without
hypertension or diabetes at baseline (Table 4).
Compared with smokers in BMI group I, smokers in
BMI group II had no significant loss of life expectancy
(Table 3). However, female and male smokers in BMI
group III had a large decrease in life expectancy compared
with normal-weight smokers: 7.2 and 6.7 years, respec-
tively (Table 3).
Although smoking status at baseline was not our pri-
mary analysis, the difference in life expectancy between
smokers and nonsmokers at 40 years of age ranged from 5
to 7 years; our findings are similar to those previously re-
ported (26) (Table 3).
Effect of BMI in Adulthood Independent of Future BMI
Overweight and obesity identified in adulthood pre-
dict substantial decreases in life expectancy; however, these
decreases may be unrelated to the effect of BMI in adult-
hood. Rather, they may be the result of the independent
effects of overweight and obesity later in life. We analyzed
whether BMI in adulthood has an effect on mortality in-
dependent of BMI later in life. The survival patterns pre-
sented in the Figure and the analysis of the mortality risks
within two distinct follow-up periods suggest that obesity
in adulthood exerts an immediate effect on mortality.
We also analyzed the patterns of change in BMI and
BMI group over 20 years of follow-up. Of the participants
who had BMI and smoking status measured at examina-
tion 10 (20 years after entry to the study, representing 64%
of those still alive), 1977 survived for at least 4 years after
this examination. Although most persons in each BMI
group were in the same BMI group 20 years earlier, a
substantial proportion of persons in BMI groups II and III
were in a lower BMI group 20 years earlier (Table 5). The
BMI at age 30 to 49 years was a significant predictor of
death from age 50 to 69 years, independent of BMI group
at 50 to 69 years of age. For persons in BMI group II or III
at age 50 to 69 years, the risk for death was significantly
higher among those who had been in BMI group III at 30
to 49 years of age (Table 5). Significant weight gain or loss
may be worse for health than is a consistent weight
Table 3. Effect of Overweight and Obesity in Adulthood on Life Expectancy at 40 Years of Age*
BMI Group† Life Expectancy or Years Lost (95% CI), y
Female Nonsmoker Female Smoker Male Nonsmoker Male Smoker
Primary analysis with all participants (n  3574)
Life expectancy at 40 years of age
Group I 46.28 (45.00 to 47.46) 40.21 (38.90 to 41.50) 43.35 (40.82 to 45.96) 36.31 (35.14 to 37.48)
Group II 42.99 (41.50 to 44.39) 40.05 (38.15 to 42.03) 40.30 (38.00 to 42.49) 35.00 (33.85 to 36.15)
Group III 39.19 (36.96 to 41.45) 33.00 (29.75 to 36.85) 37.54 (33.84 to 41.70) 29.65 (27.78 to 31.42)
Years lost from the age of 40 years relative
to BMI group I
Group II 3.29 (1.42 to 5.07) 0.16 (2.12 to 2.36) 3.05 (0.36 to 6.39) 1.30 (0.34 to 2.79)
Group III 7.08 (4.58 to 9.57) 7.21 (3.18 to 10.62) 5.82 (1.36 to 10.53) 6.66 (4.55 to 8.82)
Participants without hypertension or diabetes at
baseline (n  3025)
Life expectancy at 40 years of age
Group I 46.91 (45.64 to 48.21) 40.85 (39.41 to 42.12) 44.35 (41.64 to 47.08) 36.84 (35.70 to 38.24)
Group II 43.83 (42.12 to 45.22) 40.66 (38.62 to 43.15) 41.72 (39.45 to 44.28) 36.31 (35.09 to 37.61)
Group III 39.90 (37.25 to 42.44) 34.67 (30.98 to 38.43) 37.50 (32.94 to 43.30) 30.21 (27.92 to 32.66)
Years lost from the age of 40 years relative
to BMI group I
Group II 3.08 (1.30 to 5.11) 0.20 (2.82 to 2.39) 2.63 (0.92 to 6.06) 1.19 (1.10 to 2.26)
Group III 7.01 (4.29 to 9.98) 6.18 (2.34 to 10.20) 6.85 (0.36 to 9.98) 6.63 (4.01 to 9.37)
* All results are from life tables representing cohorts initially 40 years of age and free of cardiovascular disease. BMI  body mass index.
† Group I is normal weight, group II is overweight, and group III is obese.
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throughout adulthood, but the numbers in our study are
too small to allow valid interpretation.
With BMI as a continuous variable, BMI at age 30 to
49 years was associated with a hazard ratio of 1.05 (CI,
1.02 to 1.09) for mortality from age 50 to 69 years, after
adjustment for BMI at age 50 to 69 years, sex, age, and
smoking status. In this analysis, the mortality hazard ratio
associated with BMI at age 50 to 69 years was 1.00 (CI,
0.97 to 1.03). This finding is in contrast to the mortality
hazard ratio of 1.04 (CI, 1.02 to 1.06) associated with
BMI at age 50 to 69 years in an analysis adjusting only for
sex, age, and smoking status.
DISCUSSION
The effect of overweight and obesity in adulthood on
life expectancy and premature death is striking. Among
40-year-old nonsmokers without previously diagnosed car-
diovascular disease, overweight was associated with a 3-year
decrease in life expectancy; obesity was associated with a
7-year decrease for women and 6-year decrease for men.
These decreases were based on comparisons with persons of
normal weight at age 40 years. Because the increased mor-
tality risk is spread across all ages, there are also large in-
creases in premature mortality; compared with persons in
the normal-weight range, obese women were 115% more
likely to die before age 70 years and obese men were 81%
more likely to die before age 70 years. Our study did not
analyze underweight persons (BMI 18.5 kg/m2).
Obese smokers had a similar decrease in life expect-
ancy: They lost 7 more years of life than smokers of normal
weight. The double burden of obesity and smoking re-
sulted in obese female smokers’ losing 13 years and obese
male smokers’ losing 14 years compared with nonsmokers
of normal weight. Although overweight (BMI, 25 to 29.9
kg/m2) male smokers lost approximately 1 year of life ex-
pectancy, overweight female smokers showed no survival
disadvantage compared with smokers of normal weight.
Studies differ on the effects of smoking on the relationship
between body weight and mortality (12, 27, 28). In our
sample, the interaction between smoking status and the
effect of overweight on mortality was significant. We could
not explain this finding, even after accounting for future
smoking habits, numbers of cigarettes smoked, and medi-
um-term mortality.
Our primary analyses stratified by sex and smoking
status and adjusted only for age. Adjustment for education
and physical activity did not change the relative risks asso-
ciated with overweight and obesity. The results of our pri-
mary analyses do not differ greatly from those obtained
after analysis of only participants without hypertension or
diabetes at baseline. We argue against adjusting for such
factors as hypertension and diabetes because they are
Table 4. Effect of Overweight and Obesity in Adulthood on Premature Death between 40 and 70 Years of Age*
BMI Group† Female Nonsmoker Female Smoker Male Nonsmoker Male Smoker
Primary analysis with all participants (n  3574)
Percentage mortality between 40 and 70
years of age (95% CI), %
Group I 9.36 (7.56–11.59) 18.72 (16.10–21.74) 12.62 (8.73–17.75) 26.72 (23.58–29.73)
Group II 13.85 (11.18–16.73) 19.02 (15.50–23.28) 17.43 (12.74–23.07) 29.74 (26.53–33.03)
Group III 20.09 (15.34–24.85) 34.35 (24.90–43.84) 22.86 (14.31–32.91) 45.03 (39.11–51.57)
Number of excess deaths/100 population
relative to BMI group I, n
Group II 4.49 0.30 4.81 3.02
Group III 10.73 15.63 10.24 18.31
Percentage increased risk for premature
death relative to BMI group I, %
Group II 48.04 1.62 38.15 11.32
Group III 114.74 83.51 81.17 68.54
Participants without hypertension or diabetes at
baseline (n  3025)
Percentage mortality between 40 and 70
years of age (95% CI), %
Group I 7.99 (6.17–10.09) 18.02 (15.35–20.98) 11.42 (7.33–16.85) 24.68 (21.37–27.71)
Group II 11.86 (9.45–15.15) 18.36 (14.19–22.8) 15.42 (10.91–21.47) 25.85 (22.49–28.98)
Group III 17.82 (13.31–23.64) 30.61 (21.94–40.96) 23.37 (12.37–37.12) 42.51 (34.69–50.79)
Number of excess deaths/100 population
relative to BMI group I, n
Group II 3.86 0.34 4.00 1.17
Group III 9.83 12.59 11.95 17.83
Percentage increased risk for premature
death relative to BMI group I, %
Group II 48.31 1.89 35.01 4.74
Group III 122.94 69.88 104.60 72.22
* All results are from life tables representing cohorts initially aged 40 years and free of cardiovascular disease. BMI  body mass index.
† Group I is normal weight, group II is overweight, and group III is obese.
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downstream physiologic effects of obesity (8, 29). The de-
crease in mortality risk associated with obesity after adjust-
ment for hypertension and diabetes may reflect true con-
founding, the increased mortality risk of those with more
severe obesity (associated with early development of hyper-
tension or diabetes), or a combination of both. Further-
more, if future risk profiles are related to the association
between obesity and mortality, adjustment for any of these
during follow-up would bias assessment of the true mor-
tality risk associated with obesity.
A high degree of correlation of BMI measured
throughout adult life (30) and the uncertain long-term ef-
fects of weight loss interventions (2) support the rationale
for identifying BMI in adulthood as a target for preven-
tion. Our study confirms that the relative risk for death
associated with increased BMI in adulthood remains rela-
tively constant throughout life (12, 31). We also showed
that overweight and obesity in adulthood are strong pre-
dictors of death after taking into account future BMI (6).
As a result, overweight and obesity are even more impor-
tant targets. Our results strongly support prevention as a
first line of public health action (14, 32, 33).
Our study has several advantages when compared with
other studies. In contrast to a previous study (34), we used
observed mortality follow-up of all causes for people with
BMI classified in adulthood. Differences in life expectancy
were not as great among BMI groups in this earlier theo-
retical study, probably because the researchers limited the
consequences of obesity to only cardiovascular disease and
diabetes and kept BMI constant during the life course (34).
Our study also benefits from use of the Framingham Study
data set. The Framingham Study provides excellent long-
term follow-up on mortality and provides independently
determined data on height and weight. Without such an
extended follow-up period, it is not possible to empirically
analyze the long-term effects of overweight and obesity in
adulthood.
The most important outstanding question is to what
extent the observed association between obesity and de-
creased life expectancy is causal and applicable to today’s
populations. The risks associated with obesity that were
defined 50 years ago may not be the same as those defined
today because of differences in the obese population and
treatment. However, the hazard ratios reported here are
consistent with those derived from more recent studies (6,
8, 10, 12). For example, the first 24 years of follow-up in
the Framingham Study were associated with hazard ratios
of 1.4 for overweight in female nonsmokers and 1.8 for
obesity in female nonsmokers. The Nurses’ Health Study,
which also analyzes younger women (age 30 to 55 years),
has followed participants since 1976 and reported hazard
ratios of 1.3 to 1.6 for overweight in healthy female non-
smokers and 2.1 to 2.2 for obesity in healthy female non-
smokers (8).
Mortality rates have improved greatly over the last 50
years. However, the Framingham Heart Study cohort is
relatively healthy, and its life expectancy is similar to that
of the 1990 Massachusetts population (21, 35). After each
age-specific mortality rate is reduced by 30% (approximat-
ing the reductions in mortality between 1970 and 2000),
the loss of life expectancy associated with obesity decreased
only very slightly (data not shown). Although these results
will not represent the absolute life expectancy of today’s
populations, they are a robust estimation of the relative
magnitude of life expectancy lost due to increasing body
weight.
The major limitation of our study is that we could not
identify what proportion of the described loss of life ex-
pectancy is a direct consequence of obesity and would
therefore be prevented through obesity prevention. Obesity
clusters with other mortality risk factors, such as low phys-
ical activity levels, diabetes, hypertension, and high lipid
levels. Although we accounted for some of these factors at
baseline, physical activity level was not available until 8
Table 5. Independent Effects of Body Mass Index in Adulthood and in Older Age on Mortality*
BMI Group at Baseline† BMI Group at 20 Years after Baseline
Group I Group II Group III
Proportional distribution (number) of survivors at 20 years after baseline
by BMI group at baseline, % (n)
Group I 89 (695) 41 (352) 5 (16)
Group II 11 (84) 54 (467) 47 (160)
Group III 0.4 (3) 4 (38) 48 (162)
Hazard ratios (95% CIs) from regression on 20-year mortality of BMI
group trajectory (the combination of BMI group at baseline and 20
years later)‡
Group I 1 1.08 (0.86–1.37) 1.36 (0.51–3.68)
Group II 1.40 (1.00–1.97) 1.16 (0.94–1.42) 1.46 (1.10–1.94)
Group III NA 2.10 (1.39–3.20) 2.00 (1.54–2.58)
* BMI  body mass index; NA  not applicable.
† Group I is normal weight, group II is overweight, and group III is obese.
‡ Adjusted for sex, age, and smoking status at 20 years after baseline. The reference category is those participants who are in BMI group I at baseline and 20 years after
baseline. Participants who died within the first 4 years of survival time were excluded.
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years after the baseline examination and lipid levels were
not available in a sufficient proportion of the population. It
would be of interest to analyze the effects of obesity in
young adults still free of other related risk factors. In addi-
tion, although many of these variables were available dur-
ing follow-up, our study did not have enough power to
analyze mortality differences associated with different tra-
jectories of BMI and related risk factors. Future studies
should determine whether these large survival deficits are
associated with specific, preventable risk factor profiles or
can be avoided if an “optimal” weight trajectory is main-
tained throughout life.
We conclude that obesity in adulthood is associated
with a decrease in life expectancy of about 7 years, both in
men and women, smokers and nonsmokers. The magni-
tude of this loss is similar to that associated with smoking.
As with smoking, obesity caused increased mortality de-
cades after onset. In the Framingham Study cohort, over-
weight and obesity in middle age decrease the life expect-
ancy of nonsmokers by approximately 2 years. We expect
the potential impact on today’s populations to be much
greater because obesity is twice as prevalent in U.S. adults
now as it was in the Framingham Study (1, 2).
The smoking epidemic in the western world is waning;
however, a new fear should be the increasing prevalence of
overweight and obesity in young adults, which heralds an-
other potentially preventable public health disaster. This
time, we must pay attention earlier and firmly establish
research for more effective prevention and treatment as top
priorities in public health.
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